Skip to content

Research on the Application of Targeted Optimization of Meckel’s Cave Imaging Technology in Balloon Compression for Trigeminal Neuralgia

Research on the Application of Targeted Optimization of Meckel’s Cave Imaging Technology in Balloon Compression for Trigeminal Neuralgia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600124043
Enrollment
Unknown
Registered
2026-05-06
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Trigeminal Neuralgia

Interventions

Experimental Group:A novel double-channel visualization balloon catheter was used to perform percutaneous trigeminal gasserian ganglion balloon compression under the guidance of intraoperative dynamic

Sponsors

Nanjing Drum Tower Hospital Affiliated to Medical School of Nanjing University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Participants were eligible if they met all of the following criteria: 1. Age >=18 years old, regardless of gender; 2. Clinical diagnosis of primary trigeminal neuralgia according to the diagnostic criteria of the International Classification of Headache Disorders, 3rd edition (ICHD-3); 3. Skull base MRI examination excluded secondary causes (such as tumors, vascular malformations, multiple sclerosis, etc.) and severe anatomical structure variation of skull base; 4. American Society of Anesthesiologists (ASA) grade I or II, without contraindications to general anesthesia; 5. Voluntarily participate in this study and have signed the latest version of the informed consent form approved by the ethics committee.

Exclusion criteria

Exclusion criteria: Subjects were not eligible if they met any of the following criteria: 1. Secondary trigeminal neuralgia (due to clear causes such as cerebellopontine Angle tumors, arachnoid cysts, multiple sclerosis); 2. Known history of allergy or serious adverse reactions to iodinated contrast media such as Omnipake; 3. Severe coagulation dysfunction (unable to accept puncture surgery according to the investigator's judgment); 4. Pregnant or lactating women; 5. Patients with severe cognitive impairment or mental illness were unable to cooperate with the study evaluation and follow-up; 6. The investigator considers that there are any other conditions (such as severe heart, lung, liver, kidney dysfunction, etc.) that are not suitable for participation in the clinical study.

Design outcomes

Primary

MeasureTime frame
First-Pass Success Rate;

Secondary

MeasureTime frame
Operative Time;Number of Puncture Attempts;Radiation Exposure Dose (DAP);Pain Relief Rate at 24 Hours Postoperation;

Countries

China

Contacts

Public ContactYulong Chong

Nanjing Drum Tower Hospital Affiliated to Medical School of Nanjing University

cyl130268@163.com+86 181 2016 2654

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 16, 2026